GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » EV-to-EBIT

Angelalign Technology (HKSE:06699) EV-to-EBIT : 101.75 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Angelalign Technology's Enterprise Value is HK$7,698 Mil. Angelalign Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil. Therefore, Angelalign Technology's EV-to-EBIT for today is 101.75.

The historical rank and industry rank for Angelalign Technology's EV-to-EBIT or its related term are showing as below:

HKSE:06699' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.37   Med: 48.77   Max: 330.65
Current: 101.75

During the past 6 years, the highest EV-to-EBIT of Angelalign Technology was 330.65. The lowest was 13.37. And the median was 48.77.

HKSE:06699's EV-to-EBIT is ranked worse than
93.45% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs HKSE:06699: 101.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Angelalign Technology's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,945 Mil. Angelalign Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil. Angelalign Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.27%.


Angelalign Technology EV-to-EBIT Historical Data

The historical data trend for Angelalign Technology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology EV-to-EBIT Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - 92.31 59.04 78.58

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.31 - 59.04 - 78.58

Competitive Comparison of Angelalign Technology's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Angelalign Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's EV-to-EBIT falls into.



Angelalign Technology EV-to-EBIT Calculation

Angelalign Technology's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7698.298/75.662
=101.75

Angelalign Technology's current Enterprise Value is HK$7,698 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Angelalign Technology  (HKSE:06699) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Angelalign Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=75.662/5945.3259
=1.27 %

Angelalign Technology's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,945 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Angelalign Technology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Angelalign Technology (HKSE:06699) Business Description

Traded in Other Exchanges
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Carecapital Ea, Inc 2201 Interest of corporation controlled by you
Carecapital Management Group Llc 2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited 2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited 2201 Interest of corporation controlled by you
Feng Dai 2201 Interest of corporation controlled by you
Shore Lead Limited 2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited 2101 Beneficial owner
Li Huamin 2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited 2101 Beneficial owner
Chen Kai 2201 Interest of corporation controlled by you
Jovial Day Global Limited 2201 Interest of corporation controlled by you
Vast Luck Global Limited 2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si 2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines